19763-77-0 Usage
Uses
Used in Pharmaceutical Industry:
7,8-DIDEHYDRO-4,5-α-EPOXY-14-HYDROXY-3-METHOXY-17-METHYLMORPHINAN-6-ONE-N-OXIDE is used as a key compound in the development of new pain medications due to its strong analgesic properties. Its higher potency compared to morphine makes it a promising candidate for creating more effective treatments for severe pain.
Used in Research and Development:
In the field of medical research, 7,8-DIDEHYDRO-4,5-α-EPOXY-14-HYDROXY-3-METHOXY-17-METHYLMORPHINAN-6-ONE-N-OXIDE is utilized for studying the opioid receptor system. Understanding the interactions and mechanisms of 7,8-DIDEHYDRO-4,5-α-EPOXY-14-HYDROXY-3-METHOXY-17-METHYLMORPHINAN-6-ONE-N-OXIDE can lead to advancements in pain management and the development of safer and more effective analgesics.
Used in Drug Delivery Systems:
Similar to gallotannin, 7,8-DIDEHYDRO-4,5-α-EPOXY-14-HYDROXY-3-METHOXY-17-METHYLMORPHINAN-6-ONE-N-OXIDE could potentially benefit from novel drug delivery systems to enhance its efficacy, bioavailability, and targeted delivery to specific areas in the body. This could improve the therapeutic outcomes and reduce potential side effects associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 19763-77-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,7,6 and 3 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 19763-77:
(7*1)+(6*9)+(5*7)+(4*6)+(3*3)+(2*7)+(1*7)=150
150 % 10 = 0
So 19763-77-0 is a valid CAS Registry Number.
19763-77-0Relevant academic research and scientific papers
PRODUCTION OF 6-HYDROXY MORPHINANS WITHOUT THE ISOLATION OF INTERMEDIATES
-
Paragraph 0130, (2015/05/13)
The present invention provides a process for preparing a saturated 6,14-dihydroxy morphinan. The process comprises contacting an unsaturated 6-O-hydrocarbyl morphinan with hydrogen peroxide and an organic acid to form an unsaturated 6-keto-14-hydroxy morphinan. The unsaturated 6-keto-14-hydroxy morphinan is contacted with a first reducing agent to form an unsaturated 6,14-dihydroxy morphinan, and the unsaturated 6,14-dihydroxy morphinan is contacted with a second reducing agent to form the saturated 6,14-dihydroxy morphinan.
10-Hydroxythebaine
Proksa, Bohumil
, p. 369 - 370 (2007/10/03)
trans-10-Hydroxythebaine and (8S)-8-hydroxyoxycodone were identified as by-products of thebaine oxidation with hydrogen peroxide in acidic medium. Structures of isolated compounds were determined by spectral methods.
